Plain-English translation of NCT07497308 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study looks at a protein in your blood called GDF-15 before you receive a left ventricular assist device (LVAD)—a mechanical heart pump for people with advanced heart failure. Researchers want to see if this blood marker can help them predict which patients are at higher risk for problems after surgery, so doctors can better prepare and plan care.
Heart pump implants are lifesaving for people with severe heart failure, but some patients have complications or worse outcomes after surgery. If doctors can identify who is at higher risk beforehand using a simple blood test, they can adjust their care plans and improve safety.
You likely qualify if…
You likely don't qualify if…
You will have a blood sample taken before your heart pump surgery to measure GDF-15 levels—this is usually done as part of your regular preoperative testing. After surgery, researchers will follow your medical records to track how you recover and whether you experience any complications. The study simply observes and records what happens; you won't receive any new medication or undergo extra procedures beyond your normal surgical care.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Turkey (Türkiye)
Enrollment target
~48 participants
Started
February 2026
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
emel gündüz, md
Akdeniz University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.